Volume 37, Issue 8 pp. 1291-1296
Research Article

Designing Printable Medicinal Products: Solvent System and Carrier-Substrate Screening

Dhara Raijada

Dhara Raijada

University of Copenhagen, Faculty of Health and Medical Sciences, Department of Pharmacy, Copenhagen, Denmark.

Search for more papers by this author
Natalja Genina

Natalja Genina

Abo Akademi University, Department of Biosciences, Pharmaceutical Sciences Laboratory, Turku, Finland.

Search for more papers by this author
Daniela Fors

Daniela Fors

Abo Akademi University, Laboratory of Physical Chemistry, Center of Excellence for Functional Materials, Turku, Finland.

Search for more papers by this author
Erik Wisaeus

Erik Wisaeus

Danish Technological Institute, Center for Nano- and Microtechnology, Taastrup, Denmark.

Search for more papers by this author
Jouko Peltonen

Jouko Peltonen

Abo Akademi University, Laboratory of Physical Chemistry, Center of Excellence for Functional Materials, Turku, Finland.

Search for more papers by this author
Jukka Rantanen

Jukka Rantanen

University of Copenhagen, Faculty of Health and Medical Sciences, Department of Pharmacy, Copenhagen, Denmark.

Search for more papers by this author
Niklas Sandler

Niklas Sandler

Abo Akademi University, Department of Biosciences, Pharmaceutical Sciences Laboratory, Turku, Finland.

Search for more papers by this author
First published: 09 July 2014
Citations: 8

Abstract

More flexible yet robust manufacturing solutions are needed in the pharmaceutical industry. Tablet compaction is no longer the obvious choice for commercial-scale processing of innovative drug delivery systems. Engineering solutions have gained wide attention in the pharmaceutical industry. Technical innovations within printing are considerable solutions for future product design. Printable medicinal products of a model compound are designed and an analytical approach for imaging the model compound in the printed medicinal products is investigated. The potential implications of using a unique combination of ink solution and carrier-substrate for designing a specific crystallization process and future directions towards continuous manufacturing of personalized medicinal products are discussed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.